Infliximab for the treatment of plaque psoriasis
Jennifer S Gall, Robert E KalbState University of New York at Buffalo, School of Medicine and Biomedical Sciences, Department of Dermatology, NY, USAAbstract: Infliximab is a monoclonal antibody that targets tumor necrosis factor-α (TNFα). It is used in the treatment of a...
Guardado en:
Autores principales: | Jennifer S Gall, Robert E Kalb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/36deadb9adb34b80ae04e18b50667003 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ustekinumab in the therapy of chronic plaque psoriasis
por: Jenna L O’Neill, et al.
Publicado: (2009) -
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Santo Raffaele Mercuri, et al.
Publicado: (2010) -
Infliximab in the treatment of rheumatoid arthritis
por: A Perdriger
Publicado: (2009) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018) -
Infliximab in ulcerative colitis
por: Avi Levin, et al.
Publicado: (2008)